A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
Clinical trial NCT05916313 · RECRUITING
Trial details
- NCT number
- NCT05916313
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2027-08-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.